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Abstract 
Randomised, placebo-controlled trials are the gold standard for the assessment of 
safety and efficacy of new treatments. Although study design is challenging, success 
ultimately depends on recruitment and retention of subjects. MS-SMART 
[NCT01910259] is a multi-arm, phase 2b study in secondary progressive multiple 
sclerosis (SPMS), currently recruiting 440 patients in the UK. We describe here in 
detail our recruitment experience so far in the largest centre (planned 40% of total). 
Potentially eligible participants were identified through a number of routes: consultant 
referrals (22%); dedicated website [www.ms-smart.org] (76%); presentations at MS 
centres (0.4%), referrals from MS nurses (2%). Of c700 patients, 150 were 
uncontactable, and so 550 underwent a simple pre-screening telephone 
questionnaire. Two hundred were eligible of which 150 agreed to attend for formal 
screening and 130 were randomised. We conclude that direct consultant referral and 
a dedicated website are the most successful recruiting methods in this SPMS trial. 
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